University of Groningen scientists led by organic chemist Ben Feringa have fitted an antibiotic with a switch that allows them to activate or deactivate the drug using visible light. Earlier versions of the switch were operated with ultraviolet light.
The Feringa group has made a switchable antibiotic before, but that version wasn’t suitable for medical use as the switch was only sensitive to UV light. This is harmful for living cells (it causes sunburn) and will not penetrate very far into the body of a patient. And that is where it needs to work as the purpose of the switch is to activate the antibiotic only where it is needed.
In the new paper, which appeared last month in the Journal of the American Chemical Society, the switch has been modified to respond to infrared light. Laboratory tests with the bacterium Escherichia coli show an 8-fold increase in the effect of the antibiotic after activation. This is a proof of principle that shows it is possible to make drugs with an on/off switch. Such a switch might also be of interest for use in anti-cancer drugs, which are notoriously poisonous and can have severe side effects.
Reaching out to sustainable business owners is what Gjalt de Jong is all about. He sees the University as a director of innovation. An independent arbiter who can expedite the shift to a circular economy. To this end, he first needed to change...
In 2022, UG researchers Dr Else Starkenburg and Prof. Lisa Herzog joined the Young Academy.
Different from previous years but still surprising, fun, healthy, and for the whole family: join Groningen’s take on this year’s national weekend of science, organized by the University of Groningen (UG) and Hanze University of Applied Sciences...
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether or not you want to accept other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information